L1CAM-integrin interaction induces constitutive NF-κB activation in pancreatic adenocarcinoma cells by enhancing IL-1Β expression

Oncogene

Volumn 29, Issue 34, 2010, Pages 4766-4778

  Kiefel, H ^a   Bondong, S ^a   Erbe Hoffmann, N ^a   Hazin, J ^a   Riedle, S ^a   Wolf, J ^a   Pfeifer, M ^a   Arlt, A ^b   Schafer H ^b   Müerköster, S Sebens ^b   Altevogt, P ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

integrins; L1CAM signalling; pancreatic tumour

Indexed keywords

ALPHA5 INTEGRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; INTEGRIN LINKED KINASE; INTERLEUKIN 1BETA; NERVE CELL ADHESION MOLECULE L1; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; CARCINOMA CELL; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; ANIMAL; BIOSYNTHESIS; CARCINOMA, PANCREATIC DUCTAL; CELL ADHESION; CELL GROWTH; DRUG RESISTANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; NONOBESE DIABETIC MOUSE; PANCREATIC NEOPLASMS; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-1BETA; MICE; MICE, INBRED NOD; MICE, SCID; NEURAL CELL ADHESION MOLECULE L1; NF-KAPPA B; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION;

MUS;

EID: 77956178436     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.230     Document Type: Article

References (47)

1. 4766-4778Arlt A, Vorndamm J, Muerkoster S, Yu H, Schmidt WE, Folsch URet al. (2002). Autocrine production of interleukin 1beta confersconstitutive nuclear factor kappaB activity and chemoresistance inpancreatic carcinoma cell lines. Cancer Res 62: 910-916.
2. Attwell S, Mills J, Troussard A, Wu C, Dedhar S. (2003). Integrationof cell attachment, cytoskeletal localization, and signaling byintegrin-linked kinase (ILK), CH-ILKBP, and the tumor suppressorPTEN. Mol Biol Cell 14: 4813-4825.
3. Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE et al.(2008). Targeting cancer stem cells through L1CAM suppressesglioma growth. Cancer Res 68: 6043-6048.
4. Boo YJ, Park JM, Kim J, Chae YS, Min BW, Um JW et al. (2007). L1expression as a marker for poor prognosis, tumor progression, andshort survival in patients with colorectal cancer. Ann Surg Oncol 14:1703-1711.
5. Brummendorf T, Kenwrick S, Rathjen FG. (1998). Neural cellrecognition molecule L1: from cell biology to human hereditarybrain malformations. Curr Opin Neurobiol 8: 87-97.
6. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S.(1998). Phosphoinositide-3-OH kinase-dependent regulation ofglycogen synthase kinase 3 and protein kinase B/AKT by theintegrin-linked kinase. Proc Natl Acad Sci USA 95: 11211-11216.
7. Fogel M, Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, SmirnovA et al. (2003a). L1 expression as a predictor of progression andsurvival in patients with uterine and ovarian carcinomas. Lancet362: 869-875.
8. Fogel M, Mechtersheimer S, Huszar M, Smirnov A, Abu DA, TilgenW et al. (2003b). L1 adhesion molecule (CD 171) in developmentand progression of human malignant melanoma. Cancer Lett 189:237-247.
9. Gast D, Riedle S, Issa Y, Pfeifer M, Beckhove P, Sanderson MP et al.(2008a). The cytoplasmic part of L1-CAM controls growth and geneexpression in human tumors that is reversed by therapeuticantibodies. Oncogene 27: 1281-1289.
10. Gast D, Riedle S, Kiefel H, Sebens Muerkö ster S, Schä fer H,Schä fer MKE et al. (2008b). The RGD integrin binding site inhuman L1-CAM is important for nuclear signaling. Exp Cell Res314: 2411-2418.
11. Gast D, Riedle S, Schabath H, Schlich S, Schneider A, Issa Y et al.(2005). L1 augments cell migration and tumor growth but notbeta3 integrin expression in ovarian carcinomas. Int J Cancer 115:658-665.
12. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P,Brabletz T et al. (2005). L1, a novel target of beta-catenin signaling,transforms cells and is expressed at the invasive front of coloncancers. J Cell Biol 168: 633-642.
13. Gavert N, Sheffer M, Raveh S, Spaderna S, Shtutman M,Brabletz T et al. (2007). Expression of L1-CAM and ADAM10in human colon cancer cells induces metastasis. Cancer Res 67:7703-7712.
14. Geismann C, Morscheck M, Koch D, Bergmann F, Ungefroren H,Arlt A et al. (2009). Up-regulation of L1CAM in pancreatic ductcells is transforming growth factor beta1-and slug-dependent: rolein malignant transformation of pancreatic cancer. Cancer Res 69:4517-4526.
15. Gouveia RM, Gomes CM, Sousa M, Alves PM, Costa J. (2008).Kinetic analysis of L1 homophilic interaction: role of the first fourimmunoglobulin domains and implications on binding mechanism.J Biol Chem 283: 28038-28047.
16. Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Gast D, Joumaa Set al. (2003). ADAM10-mediated cleavage of L1 adhesion moleculeat the cell surface and in released membrane vesicles. Faseb J 17:292-294.
17. Gutwein P, Oleszewski M, Mechtersheimer S, Agmon-Levin N,Krauss K, Altevogt P. (2000). Role of Src kinases in the ADAMmediatedrelease of L1 adhesion molecule from human tumor cells.J Biol Chem 275: 15490-15497.
18. Hannigan G, Troussard AA, Dedhar S. (2005). Integrin-linked kinase:a cancer therapeutic target unique among its ILK. Nat Rev Cancer5: 51-63.
19. Hortsch M. (2000). Structural and functional evolution of the L1family: are four adhesion molecules better than one? Mol CellNeurosci 15: 1-10.
20. Issa Y, Nummer D, Seibel T, Muerkoster SS, Koch M, Schmitz-Winnenthal FH et al. (2009). Enhanced L1CAM expression onpancreatic tumor endothelium mediates selective tumor celltransmigration. J Mol Med 87: 99-112.
21. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. (2007). Cancerstatistics, 2007. CA Cancer J Clin 57: 43-66.
22. Kaifi JT, Reichelt U, Quaas A, Schurr PG, Wachowiak R,Yekebas EF et al. (2007). L1 is associated with micrometastaticspread and poor outcome in colorectal cancer. Mod Pathol 20:1183-1190.
23. Legate KR, Montanez E, Kudlacek O, Fassler R. (2006). ILK, PINCHand parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 7:20-31.
24. Maddaluno L, Verbrugge SE, Martinoli C, Matteoli G, Chiavelli A,Zeng Y et al. (2009). The adhesion molecule L1 regulatestransendothelial migration and trafficking of dendritic cells. J ExpMed 206: 623-635.
25. Maretzky T, Schulte M, Ludwig A, Rose-John S, Blobel C,Hartmann D et al. (2005). L1 is sequentially processed by twodifferently activated metalloproteases and presenilin/gamma-secretaseand regulates neural cell adhesion, cell migration, and neuriteoutgrowth. Mol Cell Biol 25: 9040-9053.
26. Mechtersheimer S, Gutwein P, Agmon LN, Stoeck A, Oleszewski M,Riedle S et al. (2001). Ectodomain shedding of L1 adhesionmolecule promotes cell migration by autocrine binding to integrins.J Cell Biol 155: 661-674.
27. Meier F, Busch S, Gast D, Goppert A, Altevogt P, Maczey E et al.(2006). The adhesion molecule L1 (CD171) promotes melanomaprogression. Int J Cancer 119: 549-555.
28. Montgomery AM, Becker JC, Siu CH, Lemmon VP, Cheresh DA,Pancook JD et al. (1996). Human neural cell adhesion molecule L1and rat homologue NILE are ligands for integrin alpha v beta 3.J Cell Biol 132: 475-485.
29. Moos M, Tacke R, Scherer H, Teplow D, Fruh K, Schachner M.(1988). Neural adhesion molecule L1 as a member of theimmunoglobulin superfamily with binding domains similar tofibronectin. Nature 334: 701-703.
30. Muerkoster S, Arlt A, Sipos B, Witt M, Grossmann M, Kloppel Get al. (2005). Increased expression of the E3-ubiquitin ligase receptorsubunit betaTRCP1 relates to constitutive nuclear factor-kappaBactivation and chemoresistance in pancreatic carcinoma cells.Cancer Res 65: 1316-1324.
31. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey Het al. (2004). A randomized trial of chemoradiotherapy andchemotherapy after resection of pancreatic cancer. N Engl J Med350: 1200-1210.
32. Novak-Hofer I, Cohrs S, Grunberg J, Friedli A, Schlatter MC,Pfeifer M et al. (2008). Antibodies directed againstL1-CAM synergize with Genistein in inhibiting growth and survivalpathways in SKOV3ip human ovarian cancer cells. Cancer Lett 261:193-204.
33. Oleszewski M, Beer S, Katich S, Geiger C, Zeller Y, Rauch U et al.(1999). Integrin and neurocan binding to L1 involves distinct Igdomains. J Biol Chem 274: 24602-24610.
34. Primiano T, Baig M, Maliyekkel A, Chang BD, Fellars S, Sadhu Jet al. (2003). Identification of potential anticancer drug targetsthrough the selection of growth-inhibitory genetic suppressorelements. Cancer Cell 4: 41-53.
35. Qian Y, Zhong X, Flynn DC, Zheng JZ, Qiao M, Wu C et al. (2005).ILK mediates actin filament rearrangements and cell migrationand invasion through PI3K/Akt/Rac1 signaling. Oncogene 24:3154-3165.
36. Reidy M, Zihlmann P, Hubbell JA, Hall H. (2006). Activation of cellsurvivaltranscription factor NFkappaB in L1Ig6-stimulated endothelialcells. J Biomed Mater Res A 77: 542-550.
37. Riedle S, Kiefel H, Gast D, Bondong S, Wolterink S, Gutwein P et al.(2009). Nuclear translocation and signalling of L1-CAM in humancarcinoma cells requires ADAM10 and presenilin/gamma-secretaseactivity. Biochem J 420: 391-402.
38. Ruppert M, Aigner S, Hubbe M, Yagita H, Altevogt P. (1995). The L1adhesion molecule is a cellular ligand for VLA-5. J Cell Biol 131:1881-1891.
39. Schneider G, Siveke JT, Eckel F, Schmid RM. (2005).Pancreatic cancer: basic and clinical aspects. Gastroenterology 128:1606-1625.
40. Sebens Muerkoster S, Kotteritzsch J, Geismann C, Gast D, Kruse ML,Altevogt P et al. (2009). alpha5-integrin is crucial for L1CAMmediatedchemoresistance in pancreatic adenocarcinoma. Int JOncol 34: 243-253.
41. Sebens Muerkoster S, Werbing V, Sipos B, Debus MA, Witt M,Grossmann M et al. (2007). Drug-induced expression of the cellularadhesion molecule L1CAM confers anti-apoptotic protection andchemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene26: 2759-2768.
42. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M,Montgomery AM. (2004). Extracellular signal-regulatedkinase (ERK)-dependent gene expression contributes to L1 celladhesion molecule-dependent motility and invasion. J Biol Chem279: 28880-28888.
43. Stoeck A, Keller S, Riedle S, Sanderson MP, Runz S, Le Naour F et al.(2006a). A role for exosomes in the constitutive andstimulus-induced ectodomain cleavage of L1 and CD44. BiochemJ 393: 609-618.
44. Stoeck A, Schlich S, Issa Y, Gschwend V, Wenger T, Herr I et al.(2006b). L1 on ovarian carcinoma cells is a binding partner forNeuropilin-1 on mesothelial cells. Cancer Lett 239: 212-226.
45. Thelen K, Kedar V, Panicker AK, Schmid RS, Midkiff BR, ManessPF. (2002). The neural cell adhesion molecule L1 potentiatesintegrin-dependent cell migration to extracellular matrix proteins.J Neurosci 22: 4918-4931.
46. Thies A, Schachner M, Moll I, Berger J, Schulze HJ, Brunner G et al.(2002). Overexpression of the cell adhesion molecule L1 isassociated with metastasis in cutaneous malignant melanoma. EurJ Cancer 38: 1708-1716.
47. Wolterink S, Moldenhauer G, Fogel M, Kiefel H, Pfeifer M, Luttgau Set al. (2010). Therapeutic antibodies to human L1CAM: functionalcharacterization and application in a mouse model for ovariancarcinoma. Cancer Res 70: 2504-2515.